Works matching IS 09697128 AND DT 2006 AND VI 13 AND IP 9

Results: 9

Immunodeficiencies: Injecting some safety into SCID gene therapy?

Published in:

Gene Therapy, 2006, v. 13, n. 9, p. 741, doi. 10.1038/sj.gt.3302663

By:

Candotti, F.;
Roifman, C.;
Puck, J. M.

Publication type:

Article

Activators of viral gene expression in polarized epithelial monolayers identified by rapid-throughput drug screening.

Published in:

Gene Therapy, 2006, v. 13, n. 9, p. 781, doi. 10.1038/sj.gt.3302676

By:

Sorscher, E. J.;
Harris, J.;
Alexander, M.;
Rottgers, A.;
Hardy, K.;
Ponnazhagan, S.;
Collawn, J. F.;
McClintock, J.;
Amsler, C. D.;
Webster, A.;
Maddry, J.;
Baker, B. J.;
Hong, J. S.

Publication type:

Article

Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.

Published in:

Gene Therapy, 2006, v. 13, n. 9, p. 744, doi. 10.1038/sj.gt.3302686

By:

Gardner, K. L.;
Kearney, J. A.;
Edwards, J. D.;
Rafael-Fortney, J. A.

Publication type:

Article

Non-viral cancer gene therapy: Beyond delivery.

Published in:

Gene Therapy, 2006, v. 13, n. 9, p. 739, doi. 10.1038/sj.gt.3302692

By:

Akhtar, S.

Publication type:

Article

Sustained expression after nonviral ocular gene transfer using mammalian promoters.

Published in:

Gene Therapy, 2006, v. 13, n. 9, p. 798, doi. 10.1038/sj.gt.3302700

By:

Kachi, S.;
Esumi, N.;
Zack, D. J.;
Campochiaro, P. A.

Publication type:

Article

The CD20/αCD20 ‘suicide’ system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells.

Published in:

Gene Therapy, 2006, v. 13, n. 9, p. 789, doi. 10.1038/sj.gt.3302705

By:

van Meerten, T.;
Claessen, M.-J.;
Hagenbeek, A.;
Ebeling, S. B.

Publication type:

Article

Readministration of helper-dependent adenovirus to mouse lung.

Published in:

Gene Therapy, 2006, v. 13, n. 9, p. 773, doi. 10.1038/sj.gt.3302712

By:

Koehler, D. R.;
Martin, B.;
Corey, M.;
Palmer, D.;
Ng, P.;
Tanswell, A. K.;
Hu, J.

Publication type:

Article

Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization.

Published in:

Gene Therapy, 2006, v. 13, n. 9, p. 752, doi. 10.1038/sj.gt.3302718

By:

Shaw, L. C.;
Pan, H.;
Afzal, A.;
Calzi, S. L.;
Spoerri, P. E.;
Sullivan, S. M.;
Grant, M. B.

Publication type:

Article

Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate.

Published in:

Gene Therapy, 2006, v. 13, n. 9, p. 761, doi. 10.1038/sj.gt.3302721

By:

Moffatt, S.;
Papasakelariou, C.;
Wiehle, S.;
Cristiano, R.

Publication type:

Article